IRCT20170306032913N5招募中2 期
evaluation the effectiveness of neoadjuvant chemoradiation in patient with borderline and unresectable pancreatic cancer
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 75 years（—）
- 性别
- All
入选标准
- •Patients over the age of 18 to 75 years who have not previously received chemotherapy or radiotherapy in the upper abdomen, ,
- •acceptable liver, kidney, and lung function, and acceptable CBC diff
- •the functional status of group 0 or one according to the ECOG definition.
- •Patient with borderline and unresectable nonmetastatic pancreatic cancer
排除标准
- •Serious concomitant systemic disorder
- •Women with a positive pregnancy test or lactating
- •Previously radiotherapy of upper abdomen
- •Have endocrine pancreatic tumors or ampullary cancer
- •Pathology other than pancreatic adenocarcinoma
研究者
相似试验
招募中
不适用
A Study on the efficacy of neoadjuvant chemotherapy with carboplatin, docetaxel and bevacizumab in patients with non-squamous non-small cell lung canceron-Squamous Non-Small Cell Lung CancerJPRN-UMIN000008817ihon University School of Medicine Itabashi Hospital28
已完成
3 期
Investigating the effect of neoadjuvant chemotherapy on locally advanced rectal cancerocally advanced Rectal cancers.IRCT20210308050628N1Hamedan University of Medical Sciences300
招募中
2 期
eoadjuvant chemotherapy in NSCLCCTRI/2016/05/006916investigator initiated study
已完成
不适用
Effect of neoadjuvant chemotherapy in patients with gastric cancerIRCT2015020220906N1Vice chancellor for Research and Technology30
尚未招募
2 期
RESPONSE OF CANCER DRUGS BEFORE SURGERY IN ESOPHAGEAL CANCER AND ALSO COMPARING TWO DIFFERENT CANCER DRUGS COMBINATIONS CISPLATIN PLUS 5FU AND PACLITAXEL AND CARBOPLATICTRI/2017/09/009658ALL INDIA INSTITUTE OF MEDICAL SCIENCES